Screener
PPH vs IBB
VanEck Pharmaceutical ETF vs iShares Biotechnology ETF
Key differences
- PPH costs 0.08% less per year.
- IBB is significantly larger than PPH — larger funds tend to be more liquid and less likely to close.
- Over the last 3 years, PPH has delivered higher annualized returns.
- IBB has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| PPH | IBB | |
|---|---|---|
| Annual cost (TER) | 0.36% | 0.44% |
| Fund size (AUM) | $966M | $7.9B |
| Since | 2011 | 2001 |
| Dividend yield | 2.12% | 0.23% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +24.5% | +39.0% |
| CAGR 3Y | +12.6% | +9.6% |
| CAGR 5Y | +9.8% | +2.7% |
| Sharpe 3Y | 0.63 | 0.38 |
| Volatility 1Y | 17.07% | 19.75% |
| Max drawdown | -29.70% | -39.82% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to PPH and IBB
Explore further